EUVIMEDEUVIMED entdecken
Crossref

Anti-inflammatory and antinociceptive effects of a novel 1,5-benzodiazepine derivative in murine models

Hanane El Fatimi, Hanane Khalki, Martin Ndayambaje, Mohamed Loughzail, Noufel Hachimi, Hachem Elaazri, Abdesselam Baouid, Mounia Oudghiri, Abdallah Naya, Youness Zaid, Loubna Khalki

Naunyn-Schmiedeberg's Archives of Pharmacology · 2026

DOI: 10.1007/s00210-026-05703-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2026. Verfasst von Hanane El Fatimi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Mohammed VI University of Sciences and Health (UM6SS), Avenue Mohammed Taieb Naciri, 82403, Casablanca, Morocco. Hauptthemen laut MEDLINE: Analgesics, Anti-Inflammatory Agents, Benzodiazepines, Pain. Die Arbeit nennt 70 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study evaluated the anti-inflammatory and analgesic potential of a novel 1,5-benzodiazepine derivative (MAL) using in vivo models and in silico molecular docking analysis. A total of 264 adult male Swiss albino mice were used for standard pharmacological investigations. MAL was administered at doses of 5, 10, 25, and 50 mg/kg. Diazepam (DZP), diclofenac, and acetaminophen (APAP) were used as reference drugs. Anti-inflammatory activity was assessed using carrageenan-induced paw edema, the air pouch model, and Evans blue-induced vascular permeability. Histopathological analysis was performed to evaluate tissue edema, leukocyte, and neutrophil infiltration. Analgesic effects were evaluated using tail-flick, hot plate, and acetic acid-induced writhing assays. Molecular docking studies were conducted to predict binding interactions of MAL with the α1A-adrenergic receptor (8THL) and COX-2 (3LN1), with results expressed as mean ± SEM. MAL significantly reduced paw edema, with maximal inhibition at 25 mg/kg (43.41% ± 4.23), compared with diclofenac (37.93% ± 3.67). Peak inhibition at 4 h reached 78.54% ± 0.43 for MAL, while 70.14% ± 0.22 for diclofenac. MAL markedly decreased leukocyte and neutrophil infiltration, vascular permeability (66.39% ± 4.18 vs 53.40% ± 4.40), and neutrophil migration in the air pouch, confirmed by histology. Analgesic activity was significant and comparable to standard drugs, supporting both central and peripheral mechanisms. Docking analysis revealed strong binding affinities (- 8.9 and - 8.5 kcal/mol), exceeding reference drugs. MAL exhibits potent anti-inflammatory and analgesic properties, particularly at 25 mg/kg, reducing neutrophil-mediated inflammation, and represents a promising candidate for further pharmacological development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnalgesicsAnti-Inflammatory AgentsBenzodiazepinesPainAnimalsMaleEdemaMiceMolecular Docking SimulationCarrageenanDisease Models, AnimalCapillary PermeabilityDose-Response Relationship, DrugAcetic AcidPain Measurement

Stichwörter der Autor:innen

1,5-benzodiazepine derivativeAnalgesic activityAnti-inflammatory effectCarrageenan-induced inflammationThermal nociceptionVascular permeability

Substanzen

AnalgesicsAnti-Inflammatory AgentsCarrageenanBenzodiazepinesAcetic Acid

Autor:innen und Institutionen

  • Mohammed VI University of Sciences and Health (UM6SS), Avenue Mohammed Taieb Naciri, 82403, Casablanca, Morocco.
  • Interdisciplinary Laboratory of Biotechnology and Health, Neurosciences and Cellular Physiology Team, Mohammed VI Higher Institute of Biosciences and Biotechnology, Avenue Mohammed Taieb Naciri, 82403, Casablanca, Moham…
  • Applied Biology for Health, Environment and Sustainable Development Team (BASED), Department of Biology and Geology, Polydisciplinary Faculty of Beni Mellal, Sultan Moulay Slimane University, Beni Mellal, Morocco.
  • Molecular Chemistry Laboratory, Department of Chemistry, Faculty of Sciences Semlalia, Cadi University Ayyad, BP 2390, 40001, Marrakech, Morocco.
  • Physiology and Physiopathology Team, Faculty of Sciences, Genomic of Human Pathologies Research Centre, Mohammed V University, Rabat, Morocco.
  • Laboratory of Immunology and Biodiversity, Faculty of Sciences Ain Chock, Hassan II University, B.P 2693, Maarif, Casablanca, Morocco.

Zitieren

APA

El Fatimi, H., Khalki, H., Ndayambaje, M., Loughzail, M., Hachimi, N., Elaazri, H., Baouid, A., Oudghiri, M., Naya, A., Zaid, Y., & Khalki, L. (2026). Anti-inflammatory and antinociceptive effects of a novel 1,5-benzodiazepine derivative in murine models. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-026-05703-0

Vancouver

El Fatimi H, Khalki H, Ndayambaje M, Loughzail M, Hachimi N, Elaazri H, et al. Anti-inflammatory and antinociceptive effects of a novel 1,5-benzodiazepine derivative in murine models. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026. doi:10.1007/s00210-026-05703-0

BibTeX
@article{ElFatimi2026,
  author = {El Fatimi, Hanane and Khalki, Hanane and Ndayambaje, Martin and Loughzail, Mohamed and Hachimi, Noufel and Elaazri, Hachem and Baouid, Abdesselam and Oudghiri, Mounia and Naya, Abdallah and Zaid, Youness and Khalki, Loubna},
  title = {Anti-inflammatory and antinociceptive effects of a novel 1,5-benzodiazepine derivative in murine models},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2026},
  doi = {10.1007/s00210-026-05703-0}
}
Kostenlos starten →